Precision Health

Dissecting Intratumoral Heterogeneity of Head and Neck Cancers

While we are still benefiting from projects like The Cancer Genome Atlas, more information about genetic/pathway alterations in each tumor is still required to better treat our patients. New technologies to dissect each tumor will provide vital information to more effectively treat each patient by aiding clinicians in selecting therapies targeting 1) major altered pathways, 2) identified stem cells and progenitor cell, and/or 3) combinatory supportive immunotherapies.

Comment No. 160